Physician profile
Vicki Brown
NPI 1952315905
$1,271.16
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $308 · 2021: $35.97 · 2022: $169 · 2023: $52.79 · 2024: $19.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $41.02 · Education: $30.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $41.02 |
| Education | $30.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $211.94 | 2019-2020 | |
| Novo Nordisk INC | $191.24 | 2019-2022 | |
| Amgen INC. | $121.73 | 2019 | |
| Glaxosmithkline, LLC. | $112.52 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.07 | 2019-2020 | |
| Amarin Pharma, INC. | $62.45 | 2019-2020 | |
| Lilly USA, LLC | $51.68 | 2020-2022 | |
| Allergan, INC. | $50.42 | 2019 | |
| Pfizer INC. | $45.40 | 2019 | |
| Astellas Pharma US INC | $43.58 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $41.98 | 2019-2020 | |
| Abbvie INC. | $41.02 | 2023-2024 | Vraylar |
| Janssen Pharmaceuticals, INC | $38.00 | 2019-2020 | |
| Tolmar, INC. | $30.90 | 2023 | |
| Merck Sharp & Dohme LLC | $26.89 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $21.31 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.50 | 2019 | |
| Mylan Specialty L.P. | $16.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.22 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $13.40 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.07 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.44 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.86 | 2020 | |
| Cranial Technologies, INC | $11.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicki Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.